TRVITrevi Therapeutics, Inc.
$12.61+19% 1Y
$12.61
$9.9952 weeks$19.49
The financials
Trevi Therapeutics, Inc. by the numbers
The next results filing is expected around Nov 12, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$21M | −$14M | n/a |
| Net income | −$18M | −$12M | n/a |
| Diluted EPS | −$0.11 | −$0.09 | n/a |
On our screens:Most shorted stocks